How Humans Evolved a Starch-Digesting Superpower Long Before Farming

Picture of Patrick Wang

Patrick Wang

Expert of Peptides | Ask me anything about Peptides | Sales Manager at AHB Lab
cover

Table of Contents

If you’ve ever felt a rush of energy after consuming a thick slice of bread or a roasted yam, you should be thankful for an amazing genetic mutation that occurred in our ancestors hundreds of thousands of years ago. Recent research has uncovered how humans evolved to become better starch digesters and how such an evolutionary trait, as it would turn out, actually predates the birth of agriculture by a long shot.

Indeed, two landmark studies-one in Nature and the other in Science-shed light on how the gene responsible for digestion of starch, AMY1, has evolved. This gene helps in the production of the enzyme amylase, which acts on starch in our mouth and breaks it down to sugars. Investigations not only delve into when this gene first duplicated but also reveal how the rise of agriculture has massively influenced its evolution.

 

The Starch-Digesting Gene: AMY1

The gene responsible for salivary amylase, AMY1, begins the digestion of starch by producing amylase in the saliva. Modern humans have multiple copies of this gene, and populations with high-starch diets-whether from grains or tubers-tend to have even more copies. This allows them to extract even more energy out of starchy foods; this trait has doubtlessly played a key role in survival within a population.

Until now, however, the origins of this gene duplication, and why AMY1 has become so prone to multiple copies, had remained unresolved. The following recent studies add a great deal to the previous knowledge about the timing of duplication and its genetic mechanism, therefore unraveling the evolutionary journey of starch-digestive capabilities in humans.

 

The Evolution of AMY1: Conflicting Timelines

While the two studies agree on the general outlines of how AMY1 evolved, they disagree on precisely when the gene first duplicated. Using one of the studies, from Peter Sudmant of the University of California, Berkeley, the gene duplication is pegged at roughly 279,000 years ago, long before agriculture took root. The other, led by Charles Lee from the Jackson Laboratory and Omer Gokcumen from the University at Buffalo, offers an even earlier timeline: perhaps the gene duplicated as long ago as 800,000 years.

That’s a striking difference, yet it does nothing to contradict the central findings: both studies confirm that agriculture’s rise did indeed affect the number of AMY1 copies found in modern-day humans.

 

Agriculture and the Surge of AMY1

Agriculture, which began around 12,000 years ago, turned wheat, yams, and rice into food staples. As these starch-rich crops became more common, people who carried extra copies of the AMY1 gene were better adapted to digesting starch and absorbing nutrition from them. In essence, the shift toward agricultural diets triggered an explosive proliferation of AMY1 gene copies in successive generations, both teams report.

The Sudmant-led study examined the genomes of 519 ancient Eurasians to go back 12,000 years. The team believed that an average of four to over seven copies of AMY1 per person increased about 5,000 years ago when agriculture spread across Europe and Asia. The increased copy number of AMY1 was a striking example of natural selection for the ability to convert starch into energy more efficiently, which helped early individuals survive and reproduce in agrarian societies.

 

Neanderthals and Denisovans: Did They Have AMY1 Duplications?

The question for the research was whether human relatives such as Neanderthals and Denisovans also carried multiple copies of the AMY1 gene. As these new studies explain, the answer is complicated.

However, Sudmant’s team found no evidence of duplicated copies of the gene in the genomes of three Neanderthals and one Denisovan. By contrast, the work of Lee and Gokcumen indicates another scenario: duplications of the gene AMY1 in some Neanderthals and Denisovans. This would suggest either that the gene duplications occurred far earlier than previously thought, or that those ancient relatives had acquired the gene copies through interbreeding with modern humans.

Whatever the exact timing, it is clear that AMY1 duplications have been a part of the human genome for a long period and such gene copies most probably played an important role in enabling early humans and their relatives to adapt to different dietary environments.

 

Why is AMY1 So Prone to Duplication?

One of the big contributions of the new studies is to explain how easily the AMY1 gene duplicates. The work by Lee and Gokcumen shows that once a specific version of the gene-a “three-copy haplotype”-arose, it served as a template for further duplications. Because of the way gene copies were arranged on the chromosomes, a process called crossing over was possible, in which DNA from two copies could mingle and copy itself.

This process explains how some populations came to have considerably more copies of the gene, while others suffered deletions. “The moment we have the three-copy haplotype, it’s the steppingstone for the evolution of this locus-we can either go up by two copies or we can go down by two,” says Charikleia Karageorgiou, a postdoctoral researcher and co-author on the study.

 

Implications for Evolutionary Biology

The revelation of duplication mechanisms of the AMY1 gene provides a wider understanding of how structural variations in the genome contribute to human evolution. “These findings are very exciting,” says Diyendo Massilani, a geneticist at Yale University, who adds that it could spur further research into how gene copy number variations have driven human adaptation. This research could also yield some clues toward understanding other genetic conditions related to gene copy number, such as Huntington’s disease.

This ability to digest starch more effectively has clearly been a valuable trait for humans over the millennia, helping to fuel the rise of agriculture and to support growing populations. And as researchers continue to unravel the many complexities in our evolutionary history, it would seem genes like AMY1 have played a very important role in shaping who we are today.

 

Conclusion

The evolution of the AMY1 gene and this starch digestion superpower give an exciting glimpse into the dynamics of human adaptability. With the timeline of duplication of AMY1 still under debate, one thing is for sure: such a genetic trait has played an important role in human survival and dietary evolution. From the first mutations that allowed early humans to digest starch a little better, through the agricultural revolution that multiplied AMY1 gene copies manyfold, this genetic story is one of resilience and adaptation.

As researchers continue to learn more about the subject, we piece together a complex puzzle of just how our ancestors evolved to develop the tools needed for them to thrive on a diet based on starchy foods, a capability that shaped human history.

At AHB Lab, we’re committed to keeping you informed on these crucial developments and their impact on our industry. Stay tuned for more insights as the election progresses!

Leave a Reply

Your email address will not be published. Required fields are marked *

公司最新訊息

睡眠經濟的轉捩點-安眠藥的恐懼

試著想像這個場景:經過漫長的一天,你的客戶終於躺在床上,閉上眼睛,準備享受期待已久的休息。但十分鐘過去了,三十分鐘過去了……睡意沒有來臨,取而代之的是今天開會的細節、明天的待辦事項,甚至是五年前的一件糗事。 他們並不是「不累」。相反的,他們精疲力竭。 這就是現代失眠的最大悖論:身體已經累垮了,但大腦卻依然在全速運轉。 你必須明白一個殘酷的事實:你並不是失去了「睡眠的能力」,而是你的大腦忘記了「如何關機」。 這不僅僅是一種感覺,這是醫學上被稱為 「過度激發 (Hyperarousal)」 的生理狀態。而誰能幫你「關掉開關」呢。 市場不再需要另一款普通的助眠劑 過去十年間,市場的主流敘事圍繞著「補充」——補充睡眠時間、補充褪黑激素、補充鎮靜劑。然而,隨著神經科學的進步與消費者數據的積累,這一舊有的範式正在崩解。我們正面臨一個全新的認知階段:失眠不再被視為單純的「缺乏睡眠」,而被重新定義為大腦功能的「過度激發」與神經網絡的「關機失敗」。 市場渴望的是一種能夠從根源上調節生物節律、且無副作用的精密解決方案。隨著消費者對長期使用藥物與激素的擔憂日益增加,傳統的鎮靜催眠藥物與合成褪黑激素市場正面臨挑戰,而標榜「天然」、「生物駭客(Bio-hacking)」與「精準修復」的功能性胜肽市場則異軍突起。 消費者心理的演變:從「昏睡」到「優化」 過去,失眠患者只求「被擊倒(Knocked out)」,因此強效的苯二氮平類藥物(Benzodiazepines)與高劑量褪黑激素佔據主導。但現代高階消費者—包括企業高管、生物駭客、注重抗衰老的族群—他們恐懼藥物帶來的認知功能下降、宿醉感以及潛在的成癮風險。他們不希望失去對大腦的控制,而是希望「優化」大腦的運作。  AHB Lab 的 SBPP (Synthetic Biopeptide Production Platform) : 合成生物肽生產平台,提供了完美不同於藥物的「強制關機」,胜肽技術被定位為一種「生物指令」,教導身體恢復原有的調節能力。 對褪黑激素的信任危機

Read More
公司最新訊息

失眠不是因為你睡不著,而是你的大腦「忘記了」怎麼關機!

「過度激發 (Hyperarousal)」的真相 你的大腦瀏覽器,為什麼關不掉? (The Deep Dive – Science) 如果把大腦比喻成一台電腦,睡眠就是「關機程序」。對於一般人來說,點擊「關機」,系統就會自動結束所有程式,風扇停止,螢幕變黑。 但對於失眠患者來說,情況截然不同。根據 神經科學分析,這就像是你點了關機,但電腦螢幕上彈出一個視窗:「警告:還有 50 個分頁正在執行中,無法關機。」 這在神經學上對應的是 「預設模式網絡 (Default Mode Network, DMN)」 的異常活躍。 正常狀態: 當我們準備睡覺時,負責警覺的 HPA 軸(壓力中樞)會降低活性,皮質醇(Cortisol)下降,褪黑激素上升。 失眠狀態:

Read More
公司最新訊息

停止「增強」你的免疫力!為什麼「平衡」才是活下來的唯一出路?

你的免疫系統是一支紀律嚴明的軍隊,還是一群失控的叛軍? 過去十年來,我們被灌輸了一個危險的觀念:「免疫力越強越好」。於是,我們在感冒季節狂吞高劑量維他命 C,購買昂貴的紫錐花與靈芝,試圖為我們的免疫系統「加油」。 但如果我告訴你,你正在資助一場體內的內戰呢? 科學真相是: 一個被盲目「增強」的免疫系統,並不會只殺死病毒。它會殺死 你。 它攻擊你的關節(類風濕性關節炎)。 它攻擊你的皮膚(乾癬、異位性皮膚炎)。 它對無害的花粉發動核打擊(嚴重過敏)。 在未來的生物科技領域,遊戲規則已經改變。未來的健康關鍵字不再是 「強度(Strength)」,而是 「智能(Intelligence)」。不是關於 「刺激」,而是關於 「平衡」。 而掌握這把平衡鑰匙的,是一組微小的生物密碼:定序胜肽(Sequenced Peptides)。   內戰模型 讓我們用一個內戰模型來重新理解你的身體。想像你的身體是一個國家,免疫系統是軍隊。 情境 軍事比喻 生理現實 後果 免疫低下

Read More